Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Compared with some other growth hormone releasing peptides, it does not cause negative effects such as increased appetite, prolactin, cortisol, etc., while ensuring the benefits of growth hormone release
Evidence-based strategies can enhance both glycemic control and weight management while minimizing adverse effects
For individuals with obesity, healthcare professionals may calculate requirements using ideal or adjusted body weight rather than actual weight to avoid overestimation
Hansen MS, Wlfel EM, Jeromdesella S, Moller JK, Ejersted C, Jorgensen NR, Eastell R, Hansen SG, Frost M
1 Although it has not yet been approved for obesity, tirzepatide has been incorporated in the 2023 ADA guidelines and categorized as very high efficacy for weight loss
US$ 21.72
US$ 22.70
US$ 21.59
US$ 23.18
